Diagnostic Challenges in Clinical Practice
The DSM-5 criterion for mixed episodes requires three concurrent manic symptoms. Distinguishing this from prior bipolar history remains difficult. In the US, many patients were treated as unipolar for years. This diagnostic error is common and often persists for years before correction.
Wellness insights
Social support networks of older adults before, during and after the COVID-19 pandemic
College Mental Health Crisis Shows Signs of Easing
Why Depression Subtypes Matter: 25 Years of Clinical Lessons
Choosing Adjunctive Therapy for Major Depressive Disorder: A Focus on Non-NegotiablesNational VA Mental Health Program Findings
The US Department of Veterans Affairs evaluated over 2,000 patients. Methods included medical record review and videoconferencing. Many were referred for diagnostic consultation due to suspected bipolar signs. Most had previously received antidepressants despite bipolar history.
Using Narrative Descriptions to Improve Diagnosis
Descriptive narratives of hypomanic episodes aid short evaluations. These cover all DSM-5-TR symptoms. They show the typical trajectory from onset to resolution. Patients often recognize their own experience for the first time. This helps confirm or deny the description based on personal history.
Pre-Bipolar Phase and Predictive Factors
Even without clear manic history, patients may be in a pre-bipolarphase. This indicates high probability of future manic episodes. A panel of experts identified predictive factors. These include family history of bipolar disorder. Other factors: young age at onset, panic-level anxiety, family history of suicide, irritability after antidepressants, and psychotic symptoms.
Pharmacological Treatment Approaches
When predictive factors are present, use bipolar depression medications. Avoid standard antidepressants. Two FDA-approved therapies showed efficacy in placebo-controlled trials. The VA/DoD practice guide and Harvard South Shore algorithm recommend specific drugs. These include quetiapine, lurasidone, cariprazine, lumateperone, and lithium plus lamotrigine. Drug choice must consider medical status, side effects, patient preference, and local availability. Cariprazine and lumateperone are expensive and may have access restrictions.
Managing Treatment Resistance
If initial medication fails or causes intolerance, switch to another recommended regimen. If response remains unsatisfactory, try a standard antidepressant like bupropion or an SSRI. However, avoid these if there is a history of rapid cycling or worsening after prior antidepressant use. In such cases, explore more combinations of the five initial regimens. Then consider options for treatment-resistant bipolar depression, though clinical evidence is limited.
Research Needs and Expert Leadership
There is an urgent need for more research on treating mixed features. Dr. Osser, associate professor of psychiatry at Harvard Medical School and VA Boston, coordinates the national telemedicine program for bipolar disorders at the Department of Veterans Affairs.
